Meet the Team
Experts with deep professional experience and personal exposure to rare diseases
Jack has been doing biopharma marketing for more than 4 decades. He has extensive experience in development, disease education, prelaunch and launch experience in virtually every therapeutic category in the industry. He’s worked on the launch of more than 100 biopharma products and has worked on rare disease products for 30 years.
In 2000, Jack co-founded Group DCA, an innovative leader in providing interactive and digital solutions to the pharmaceutical and biotechnology industry. At Group DCA, he pioneered the application of interactive techniques to adult learning theory, created the concept of online active learning, and leveraged digital technology to more effectively educate healthcare professionals and consumers.
Before starting Group DCA, Jack was president/COO of Euro RSCG Healthview, president of McCann-Erickson Consumer Health, chief strategy officer for McCann-Erickson WorldHealth, and the founder of The BioGenesis Group, the first and most successful marketing communications and consulting company focused on the biotechnology industry.
Personal experience with rare disease
Like many individuals in the rare disease world, he also has deep personal experience with rare diseases. In the 1990s, Jack’s maternal aunt was diagnosed with ALS after a long diagnostic journey. Soon after she passed away, his uncle was also diagnosed with ALS and eventually succumbed to the disease. In the 2000s, Jack’s father-in-law, who lived close by, was diagnosed with late-onset Huntington’s disease, and he experienced the personal and family struggles first-hand. And then, about 10 years ago, one of his sons was diagnosed with an extremely rare condition, the Carney-Stratakis Syndrome. His motivation to improve patient, caregiver, and healthcare professional education is driven by his personal experiences
David holds 17 years of experience in design, digital marketing, and digital product development. David has been a creative director at fortune 500 companies and served as executive director of UX and Product Development at Group DCA, a leading provider of online healthcare promotion.
There he was responsible for leading the development of over 300 digital marketing programs for brands at the top 20 pharmaceutical and biotech companies. David also developed and successfully commercialized 3 innovative digital products for the company.
David holds dozens of awards for his innovative work. He was most recently awarded a Webby Award for Votetocracy.com, which he co-founded, and a W3 award.
Teagan is a highly skilled digital analyst with five years of experience in digital marketing and web development. He has effectively combined his analytical skills and understanding of market dynamics to excel in the digital domain. His expertise spans across critical areas such as SEO optimization, PPC campaign management, and web analytics.
Teagan's proficiency in tools such as Google Analytics, Adobe Analytics, and SQL, combined with a talent for presenting complex data in an understandable format, has made a marked difference in campaign performance and strategy formulation.
His blend of technical know-how, strategic thinking, and a results-driven mindset makes him a valuable asset in any digital marketing team.
Jeff is an industry veteran with more than 20 years of healthcare communications experience. Much of his career has been spent working with biopharma on very specialized products. Jeff‘s extensive specialty experience has taught him the value of applying non-conventional approaches to his client’s marketing challenges. He believes strongly in leveraging technologies successfully utilized in other industries.
Personal experience with rare disease
As a father of a very special boy with a rare disorder, Jeff is passionate about finding more effective ways to educate and empower patients so they may advocate for their own care.
Juan's expertise in the biopharma industry spans over 45 years, during which he has consistently demonstrated exceptional insight leadership. His track record is defined by his unwavering commitment to assisting clients in effectively bringing in the voice of the customer to develop, launch and market life science innovations. His experience includes supporting the launch of industry-leading products across a wide range of therapeutic areas including anti-infectives, dermatology, cardiology, erectile dysfunction hematology and oncology, pain therapeutics, schizophrenia, and several rare and ultra-rare diseases.
In 2002, Juan co-founded Bell Falla and Associates, a marketing research company recognized for its unique client-partner model and having the expertise to support a wide range of engagements requiring the application of innovative qualitative and quantitative methods. At the firm, Juan used his client-side pharma marketing experience to assist clients apply market research methods in nontraditional domains, including clinical scale development and quality of life studies.
Before founding Bell Falla and Associates, Juan was a member of the executive team at Shachtman Fagan Inc., a long-established marketing research firm, and held positions of increasing responsibility in marketing research and product management at Pfizer Pharmaceuticals and Forest Laboratories (now Allergan).
Juan holds a bachelor’s degree and MBA from Rutgers University.
Personal experience with rare disease
Having experienced the challenges and emotional toll that rare diseases brought to close family members, and having interviewed 100s of caregivers of individuals suffering from a rare disease, Juan has developed a deep understanding of the pressing need for enhanced efforts in diagnosing and treating rare diseases.
